What do we really know about the ubiquitin-proteasome pathway in muscle atrophy?
- PMID: 11517350
- DOI: 10.1097/00075197-200105000-00003
What do we really know about the ubiquitin-proteasome pathway in muscle atrophy?
Abstract
Studies of many different rodent models of muscle wasting have indicated that accelerated proteolysis via the ubiquitin-proteasome pathway is the principal cause of muscle atrophy induced by fasting, cancer cachexia, metabolic acidosis, denervation, disuse, diabetes, sepsis, burns, hyperthyroidism and excess glucocorticoids. However, our understanding about how muscle proteins are degraded, and how the ubiquitin-proteasome pathway is activated in muscle under these conditions, is still very limited. The identities of the important ubiquitin-protein ligases in skeletal muscle, and the ways in which they recognize substrates are still largely unknown. Recent in-vitro studies have suggested that one set of ubquitination enzymes, E2(14K) and E3(alpha), which are responsible for the 'N-end rule' system of ubiquitination, plays an important role in muscle, especially in catabolic states. However, their functional significance in degrading different muscle proteins is still unclear. This review focuses on the many gaps in our understanding of the functioning of the ubiquitin-proteasome pathway in muscle atrophy, and highlights the strengths and limitations of the different experimental approaches used in such studies.
Similar articles
-
Evaluation of signals activating ubiquitin-proteasome proteolysis in a model of muscle wasting.Am J Physiol. 1999 May;276(5):C1132-8. doi: 10.1152/ajpcell.1999.276.5.C1132. Am J Physiol. 1999. PMID: 10329962
-
The balance between glucocorticoids and insulin regulates muscle proteolysis via the ubiquitin-proteasome pathway.Miner Electrolyte Metab. 1999 Jul-Dec;25(4-6):220-3. doi: 10.1159/000057451. Miner Electrolyte Metab. 1999. PMID: 10681643
-
Muscle wasting in a rat model of long-lasting sepsis results from the activation of lysosomal, Ca2+ -activated, and ubiquitin-proteasome proteolytic pathways.J Clin Invest. 1996 Apr 1;97(7):1610-7. doi: 10.1172/JCI118586. J Clin Invest. 1996. PMID: 8601625 Free PMC article.
-
Role of the ubiquitin-proteasome pathway in sepsis-induced muscle catabolism.Mol Biol Rep. 1999 Apr;26(1-2):71-6. doi: 10.1023/a:1006916206260. Mol Biol Rep. 1999. PMID: 10363650 Review.
-
The ubiquitin-proteasome pathway: review of a novel intracellular mechanism of muscle protein breakdown during sepsis and other catabolic conditions.Ann Surg. 1997 Mar;225(3):307-16. doi: 10.1097/00000658-199703000-00011. Ann Surg. 1997. PMID: 9060588 Free PMC article. Review.
Cited by
-
Various jobs of proteolytic enzymes in skeletal muscle during unloading: facts and speculations.J Biomed Biotechnol. 2012;2012:493618. doi: 10.1155/2012/493618. Epub 2012 Feb 8. J Biomed Biotechnol. 2012. PMID: 22496611 Free PMC article. Review.
-
Sasa quelpaertensis leaf extract mitigates fatigue and regulates the transcriptome profile in mice.Genes Genomics. 2019 Mar;41(3):317-324. doi: 10.1007/s13258-018-0765-2. Epub 2018 Nov 17. Genes Genomics. 2019. PMID: 30448902
-
Alternative splicing diversifies the skeletal muscle transcriptome during prolonged spaceflight.Skelet Muscle. 2022 May 31;12(1):11. doi: 10.1186/s13395-022-00294-9. Skelet Muscle. 2022. PMID: 35642060 Free PMC article.
-
Molecular Mechanisms of Muscle Fatigue.Int J Mol Sci. 2021 Oct 27;22(21):11587. doi: 10.3390/ijms222111587. Int J Mol Sci. 2021. PMID: 34769017 Free PMC article. Review.
-
Myotoxic reactions to lipid-lowering therapy are associated with altered oxidation of fatty acids.Endocrine. 2009 Feb;35(1):38-46. doi: 10.1007/s12020-008-9126-2. Epub 2008 Dec 3. Endocrine. 2009. PMID: 19051066 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
